Horizon Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-287
Closed -$224K 90
2024
Q1
$224K Buy
+287
New +$204K 0.06% 72
2022
Q3
Sell
-1,662
Closed -$539K 93
2022
Q2
$539K Buy
1,662
+140
+9% +$42K 0.22% 49
2022
Q1
$436K Buy
1,522
+4
+0.3% +$1.03K 0.14% 59
2021
Q4
$419K Buy
+1,518
New +$385K 0.12% 64

Other funds holding LLY

Horizon Wealth Management's LLY Position: Q2 2024 in Review

Horizon Wealth Management sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 287 shares — an estimated $224K sold.

Horizon Wealth Management first reported a position in LLY in Q4 2021 and held it in 4 quarters. The position peaked at $539K in Q2 2022. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Horizon Wealth Management reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Horizon Wealth Management sold 287 Eli Lilly shares in Q2 2024, an estimated $224K.
  • Horizon Wealth Management first reported a position in Eli Lilly in Q4 2021 and held it in 4 quarters.
  • Horizon Wealth Management's Eli Lilly position peaked at $539K in Q2 2022.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Horizon Wealth Management's 13F filing for Q2 2024, filed 22 Jul 2024.